nisoldipine has been researched along with Hypertension, Renovascular in 5 studies
Nisoldipine: A dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.
nisoldipine : A racemate consisting of equimolar amounts of (R)- and (S)-nisoldipine. A calcium channel blocker, it is used in the treatment of hypertension and angina pectoris.
methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a methoxycarbonyl group at position 3, an o-nitrophenyl group at position 4, and an isobutoxycarbonyl group at position 5. The racemate, a calcium channel blocker, is used in the treatment of hypertension and angina pectoris.
Hypertension, Renovascular: Hypertension due to RENAL ARTERY OBSTRUCTION or compression.
Excerpt | Relevance | Reference |
---|---|---|
"In patients with chronic renal failure, decrement in BP was 25/16 mmHg (systolic and diastolic BP, respectively)." | 6.65 | [Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension]. ( Breuer, G; Kaufmann, W; Wambach, G, 1984) |
"In patients with chronic renal failure, decrement in BP was 25/16 mmHg (systolic and diastolic BP, respectively)." | 2.65 | [Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension]. ( Breuer, G; Kaufmann, W; Wambach, G, 1984) |
"Nisoldipine treatment for five months prevented a rise in blood pressure in Cohen diabetic rats with Goldblatt hypertension, compared to a significant elevation in untreated controls." | 1.29 | Effects of nisoldipine on hypertension and glomerulosclerosis in Cohen diabetic rat with Goldblatt hypertension. ( Cohen, AM; Rosenmann, E; Rosenthal, T, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wambach, G | 1 |
Breuer, G | 1 |
Kaufmann, W | 1 |
Kazda, S | 1 |
Garthoff, B | 1 |
Meyer, H | 1 |
Schlossmann, K | 1 |
Stoepel, K | 1 |
Towart, R | 1 |
Vater, W | 1 |
Wehinger, E | 1 |
Rosenthal, T | 3 |
Grossman, E | 2 |
Rosenmann, E | 1 |
Cohen, AM | 1 |
1 trial available for nisoldipine and Hypertension, Renovascular
Article | Year |
---|---|
[Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension].
Topics: Adult; Aged; Aldosterone; Calcium Channel Blockers; Electrolytes; Female; Heart Rate; Humans; Hydroc | 1984 |
4 other studies available for nisoldipine and Hypertension, Renovascular
Article | Year |
---|---|
Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552).
Topics: Animals; Blood Coagulation; Calcium; Cats; Chemical Phenomena; Chemistry; Diuresis; Dogs; Female; Gu | 1980 |
Nisoldipine for hypertension.
Topics: Animals; Disease Models, Animal; Humans; Hypertension; Hypertension, Renovascular; Nisoldipine; Rats | 1994 |
Effects of nisoldipine on hypertension and glomerulosclerosis in Cohen diabetic rat with Goldblatt hypertension.
Topics: Animals; Blood Pressure; Blood Urea Nitrogen; Creatinine; Diabetes Mellitus, Experimental; Diabetic | 1993 |
The hypotensive effect of nisoldipine in renovascular hypertensive rats.
Topics: Animals; Antihypertensive Agents; Calcium Channel Blockers; Hypertension, Renovascular; Nifedipine; | 1986 |